Novel Life Science Reagents
| Product Number | Product Name | CAS RN | Molecular Formula | Application |
| CLN17635 | Aflibercept | 862111-32-8 | ||
| CLN16497 | Adalimumab | 331731-18-1 | ||
| CLN17634 | Atezolizumab | 1380723-44-3 | ||
| CLN16506 | Eculizumab | 219685-50-4 | ||
| CLN16489 | Bevacizumab | 216974-75-3 | ||
| CLN16490 | Rituximab | 174722-31-7 | ||
| CLN14622 | Org 27569 | 868273-06-7 | C24H28ClN3O | |
| CLN17630 | GSK2193874 | 1336960-13-4 | C37H38BrF3N4O | |
| CLN13731 | GSK-690693 | 937174-76-0 | C21H27N7O3 | |
| CLN13708 | Cobimetinib (GDC-0973) | 934660-93-2 | C21H21F3IN3O2 |
|
| C14205 | Resatorvid (TAK-242) | 243984-11-4 | C15H17ClFNO4S | |
| C14357 | Y-27632 Dihydrochloride | 129830-38-2 | C14H21N3O.2HCl | |
| C14234 | Temoporfin | 122341-38-2 | C₄₄H₃₂N₄O₄ | |
| C13753 | ICG-001 | 847591-62-2 | C33H32N4O4 | |
| C14291 | Trastuzumab | 180288-69-1 | C6470H10012N1726O2013S42 | Antineoplastic Agent |
Products
- Category
- Active Pharmaceutical Ingredients
- Pharmaceutical Intermediates
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies & Fusion Protein
- Bioactive Small Molecules
- Stable Isotope Labelled Compounds
- Cytokines
- Dye Reagents
- Drug Impurities & Metabolites
- Natural Products
- Building Blocks & Specialty Chemicals
